Emtricitabine And Tenofovir Disoproxil Fumarate Tablet, Film Coated
Product Images NDC 69097-741

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Emtricitabine And Tenofovir Disoproxil Fumarate (NDC 69097-741). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Cipla Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (5c5923b3 5dce 40ab B987 3a69cf4fc9e9 01)

FDA Label Image

Image (5c5923b3 5dce 40ab B987 3a69cf4fc9e9 02)

FDA Label Image

30 Tablets (5c5923b3 5dce 40ab B987 3a69cf4fc9e9 03)

30 Tablets (5c5923b3 5dce 40ab B987 3a69cf4fc9e9 03)
This seems to be a description of a medicine tablet. The tablet is film-coated and contains two active ingredients: Emtricitabine and Tenofovir Disoproxil Fumarate, for treating HIV infections. The manufacturing company is Cipla L., located in India. The medication should be dispensed only in the original container and kept out of the reach of children. The pharmacist should provide the accompanying medication guide to each patient. The rest of the text contains manufacturing and labeling information.*
FDA Label Image

Container-appco (5c5923b3 5dce 40ab B987 3a69cf4fc9e9 04)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.